Ostrowski Erik 4
4 · Akebia Therapeutics, Inc. · Filed Feb 4, 2026
Research Summary
AI-generated summary of this filing
Akebia (AKBA) CFO Erik Ostrowski Sells 34,951 Shares
What Happened
Erik Ostrowski (SVP, Chief Financial Officer, Chief Business Officer & Treasurer) disposed of 34,951 Akebia shares in an S-coded sale on Feb 2, 2026 at $1.39 per share, for proceeds of $48,582. This was a sale (not a purchase), and the filing indicates it included automatic tax-withholding related to RSU vesting and was executed under a pre-established 10b5-1 plan.
Key Details
- Transaction date and price: Feb 2, 2026 — 34,951 shares sold at $1.39 each (total $48,582).
- Shares owned after transaction: Not disclosed in the provided filing.
- Footnotes:
- F1 — Sale made automatically by the issuer to cover tax withholding on one-third of RSUs that vested/settled (RSUs granted Jan 31, 2025).
- F2 — Sale executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on Sep 8, 2025.
- Filing date: Feb 4, 2026 — appears timely (filed within two business days of the transaction).
Context
Tax-withholding sales and trades under 10b5-1 plans are common and generally routine; they do not by themselves indicate a view on the company’s prospects. This report documents a disposition tied to RSU settlement and an established trading plan rather than an opportunistic open-market sale unrelated to compensation or plan rules.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-02-02$1.39/sh−34,951$48,582→ 672,635 total
Footnotes (2)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025.
- [F2]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.